Cargando…

CLEC14A was up-regulated in hepatocellular carcinoma and may function as a potential diagnostic biomarker

OBJECTIVE: The current work aimed to investigate the expression and potential clinical significance of C-type Lectin domain family 14 (CLEC14A) in hepatocellular carcinoma. METHODS: The relative expressions of CLEC14A in the Hepatocellular Carcinoma (HCC) tissue and adjacent normal tissue of 105 HCC...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yan, Lang, Li, Xiang, Yuan, Yunfeng
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hospital das Clinicas da Faculdade de Medicina da Universidade de Sao Paulo 2022
Materias:	Original Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9118534/ https://www.ncbi.nlm.nih.gov/pubmed/35576868 http://dx.doi.org/10.1016/j.clinsp.2022.100029

Ejemplares similares

CLEC3B as a Potential Prognostic Biomarker in Hepatocellular Carcinoma
por: Xie, Xing-Wei, et al.
Publicado: (2021)

Comprehensive analysis identifies CLEC1B as a potential prognostic biomarker in hepatocellular carcinoma
por: Jing, Qiangan, et al.
Publicado: (2023)

CLEC4s as Potential Therapeutic Targets in Hepatocellular Carcinoma Microenvironment
por: Zhang, Yinjiang, et al.
Publicado: (2021)

CLEC1B is a Promising Prognostic Biomarker and Correlated with Immune Infiltration in Hepatocellular Carcinoma
por: Liang, Xiaoliang, et al.
Publicado: (2022)

CLEC3B as a potential diagnostic and prognostic biomarker in lung cancer and association with the immune microenvironment
por: Sun, Jiaxing, et al.
Publicado: (2020)

NRAGE is a potential diagnostic biomarker of hepatocellular carcinoma
por: Zou, Wenshuang, et al.
Publicado: (2018)

CLEC4M overexpression inhibits progression and is associated with a favorable prognosis in hepatocellular carcinoma
por: Yu, Qianle, et al.
Publicado: (2020)

High expression levels of CLEC4M indicate poor prognosis in patients with hepatocellular carcinoma
por: Luo, Liuping, et al.
Publicado: (2020)

Discovery of CLEC2B as a diagnostic biomarker and screening of celastrol as a candidate drug for psoriatic arthritis through bioinformatics analysis
por: Niu, Min, et al.
Publicado: (2023)

Centromere protein N may be a novel malignant prognostic biomarker for hepatocellular carcinoma
por: Wang, Qingqing, et al.
Publicado: (2021)

Modified AS1411 Aptamer Suppresses Hepatocellular Carcinoma by Up-Regulating Galectin-14
por: Cho, Yuri, et al.
Publicado: (2016)

The Circular RNA hsa_circ_0001445 Regulates the Proliferation and Migration of Hepatocellular Carcinoma and May Serve as a Diagnostic Biomarker
por: Zhang, Xianwei, et al.
Publicado: (2018)

Downregulation of exosomal CLEC3B in hepatocellular carcinoma promotes metastasis and angiogenesis via AMPK and VEGF signals
por: Dai, Wenjuan, et al.
Publicado: (2019)

A novel prognostic biomarker SPC24 up-regulated in hepatocellular carcinoma
por: Zhu, Pengpeng, et al.
Publicado: (2015)

CLEC2 and CLEC5A: Pathogenic Host Factors in Acute Viral Infections
por: Sung, Pei-Shan, et al.
Publicado: (2019)

Circulating microRNAs as Potential Diagnostic and Prognostic Biomarkers in Hepatocellular Carcinoma
por: Jin, Yu, et al.
Publicado: (2019)

Cell Cycle Genes Are Potential Diagnostic and Prognostic Biomarkers in Hepatocellular Carcinoma
por: Liping, Xu, et al.
Publicado: (2020)

Circular RNAs 0064286 and 0000475: Potential Diagnostic Biomarkers in Hepatocellular Carcinoma
por: El Sharkawi, Fathia Zaky, et al.
Publicado: (2021)

Exonuclease 1 is a Potential Diagnostic and Prognostic Biomarker in Hepatocellular Carcinoma
por: Ma, Jiaxiu, et al.
Publicado: (2022)

Circulating Non-Coding RNAs as Potential Diagnostic Biomarkers in Hepatocellular Carcinoma
por: Chen, Tingsong
Publicado: (2022)

Downregulated Expression of CLEC9A as Novel Biomarkers for Lung Adenocarcinoma
por: Miao, Fang, et al.
Publicado: (2021)

Activin receptor-like kinase 1 is associated with immune cell infiltration and regulates CLEC14A transcription in cancer
por: Bocci, Matteo, et al.
Publicado: (2018)

CLEC14a-HSP70-1A interaction regulates HSP70-1A-induced angiogenesis
por: Jang, Jihye, et al.
Publicado: (2017)

PUS1 May Be a Potential Prognostic Biomarker and Therapeutic Target for Hepatocellular Carcinoma
por: Lan, Chenlu, et al.
Publicado: (2023)

Identification of CD14 as a potential biomarker of hepatocellular carcinoma using iTRAQ quantitative proteomics
por: Guo, Jiao, et al.
Publicado: (2017)

Blocking CLEC14A-MMRN2 binding inhibits sprouting angiogenesis and tumour growth
por: PJ, Noy, et al.
Publicado: (2015)

Inhibition of VEGF‐dependent angiogenesis and tumor angiogenesis by an optimized antibody targeting CLEC14a
por: Kim, Taek‐Keun, et al.
Publicado: (2018)

CAR T cells targeting tumor endothelial marker CLEC14A inhibit tumor growth
por: Zhuang, Xiaodong, et al.
Publicado: (2020)

An evaluation of the tumour endothelial marker CLEC14A as a therapeutic target in solid tumours
por: Robinson, Joseph, et al.
Publicado: (2020)

CLEC1B Expression and PD-L1 Expression Predict Clinical Outcome in Hepatocellular Carcinoma with Tumor Hemorrhage()()
por: Hu, Kuan, et al.
Publicado: (2018)

CLEC16A—An Emerging Master Regulator of Autoimmunity and Neurodegeneration
por: Pandey, Rahul, et al.
Publicado: (2023)

Corrigendum to “Cell Cycle Genes Are Potential Diagnostic and Prognostic Biomarkers in Hepatocellular Carcinoma”
por: Liping, Xu, et al.
Publicado: (2020)

CD69 serves as a potential diagnostic and prognostic biomarker for hepatocellular carcinoma
por: Tang, Kaihua, et al.
Publicado: (2023)

Biomarkers for hepatocellular carcinoma: diagnostic and therapeutic utility
por: Ferrín, Gustavo, et al.
Publicado: (2015)

RHBDF2 is correlated with immune infiltrates in hepatocellular carcinoma and may have potential as a biomarker
por: Gong, Hanjuan, et al.
Publicado: (2023)

EIF5A expression and its role as a potential diagnostic biomarker in hepatocellular carcinoma
por: Li, Linjing, et al.
Publicado: (2021)

Seven chromatin regulators as immune cell infiltration characteristics, potential diagnostic biomarkers and drugs prediction in hepatocellular carcinoma
por: Chai, Jin-wen, et al.
Publicado: (2023)

The uric acid crystal receptor Clec12A potentiates type I interferon responses
por: Li, Kai, et al.
Publicado: (2019)

Investigation of Diagnostic and Prognostic Value of CLEC4M of Non-Small Cell Lung Carcinoma Associated with Immune Microenvironment
por: Liu, Huan, et al.
Publicado: (2023)

Clec14a genetically interacts with Etv2 and Vegf signaling during vasculogenesis and angiogenesis in zebrafish
por: Pociute, Karolina, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_4tmgartij3vdrke4jo5uj4hohn